According to the official website of the State Food and drug administration, the State Food and Drug Administration recently announced that Pudilan anti-inflammatory tablets and safflower Xiaoyao tablets have been converted from prescription drugs to over-the-counter drugs after organizational demonstration and approval. The State Food and Drug Administration said that the holders of relevant drug marketing licenses are requested to file the revision of the instructions with the provincial drug regulatory department in accordance with the measures for the administration of drug registration and other relevant provisions before April 19, 2022, and timely notify the relevant medical institutions, drug trading enterprises and other units of the revision of the instructions. In addition, the contents of the manual other than those specified in the model manual of OTC drugs shall be implemented in accordance with the original approval certificate. If the drug label involves relevant contents, it shall be revised at the same time. Drugs produced since the date of supplementary application for filing shall not continue to use the original drug instructions. The data show that the main functions of Pudilan anti-inflammatory tablets are clearing away heat and detoxification, anti-inflammatory and detumescence. For furuncle, pharyngitis and tonsillitis. Medication contraindications include: it is forbidden for those who are allergic to this product and its ingredients. The main functions of Honghua Xiaoyao tablet are soothing liver, regulating qi and promoting blood circulation. It is used for chest and flank pain, dizziness, loss of appetite, irregular menstruation, breast pain or face chloasma caused by liver Qi discomfort. Drug contraindications include: pregnant women should not take. It is forbidden for those who are allergic to this product and its ingredients. (outlook new era)